- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03120507
Resuscitation Outcomes in the Netherlands (ROUTiNE)
Resuscitation Outcomes in the Netherlands Study
Study Overview
Status
Detailed Description
Background: In-hospital cardiac arrest (IHCA) is a serious adverse event for which cardiopulmonary resuscitation (CPR) can be performed to restore circulation. Currently survival after IHCA is poor. To assess the success of resuscitation attempts there is a need for research that focuses on long-term survival and quality of life. Patient selection for CPR, prevention of cardiac arrest and improvement of CPR techniques are crucial for improving qualitative survival. To assess the feasibility of this project a single-center retrospective cohort study was conducted over a 10-year period in the OLVG hospital. For all patients who received CPR survival to discharge was 32% and one-year survival was 22%. This is slightly higher than survival reported in contemporary literature. Due to it's design no prognostic variables could be derived from this study, however data suggested age and Charlson Comorbidity Index could prove useful in predicting long-term outcome. In the consecutive year this study was designed.
Hypothesis: The hypothesis is that one-year survival after IHCA in Dutch hospitals is poor, consistent with international literature and our feasibility trial, and survival can be improved through selection, prevention and training.
Objective: The main objective of this study is to assess the one-year survival of patients after CPR for in-hospital cardiac arrest. The secondary objectives are to assess quality of life and functional status after successful CPR. Furthermore the investigators aim to assess if there are patient-related predicting factors for these outcome measures and to assess whether outcomes are influenced by hospital-related factors (i.e. CPR training and treatment options).
Study design: The current study has a prospective, observational design, with a 12-month follow-up. Patients will be included from January 1st 2017. Patient data collection will take place at four time points: T0= directly post-CPR, T1= at hospital discharge or at in-hospital death, T2= 3 months after CPR, T3= 12 months after CPR. Clinical data will be collected at all time points. Quality of life data will be collected at T2 and T3 by means of validated questionnaires. We will assess functional status through questionnaires and link these to pre-existing and acquired comorbidities (e.g. stroke). General hospital data and data concerning the level of CPR-training will be ascertained at four moments during the first year of patient inclusion.
Study population: An estimated six hundred patients of 18 years or older who will receive CPR for cardiac arrest in the participating hospitals. This will include all cases of in-hospital cardiac arrest, also including Operation Room (OR), Intensive/Coronary Care Unit (ICU/CCU) and Emergency Department (ER). Patients in whom CPR was started before arrival in hospital will be excluded.
Expected results: The main study endpoints are one-year survival and quality of life. Secondary endpoints are direct survival and survival to discharge. The first preliminary results are expected in the first quarter of 2018. After conclusion of this project the investigators of this project aim to develop recommendations that will improve survival after IHCA.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Gelderland
-
Arnhem, Gelderland, Netherlands, 6815AD
- Rijnstate Ziekenhuis
-
-
Noord-Holland
-
Amsterdam, Noord-Holland, Netherlands, 1091AC
- OLVG
-
-
Overijssel
-
Deventer, Overijssel, Netherlands, 7416SE
- Deventer Ziekenhuis
-
Enschede, Overijssel, Netherlands, 7512KZ
- Medisch Spectrum Twente
-
Zwolle, Overijssel, Netherlands, 8025AB
- Isala Klinieken
-
-
Zeeland
-
Terneuzen, Zeeland, Netherlands, 4535PA
- Zorgsaam Zeeuws-Vlaanderen
-
-
Zuid-Holland
-
Breda, Zuid-Holland, Netherlands, 4818CK
- Amphia Ziekenhuis
-
Delft, Zuid-Holland, Netherlands, 2625AD
- Reinier de Graaf Gasthuis
-
Dordrecht, Zuid-Holland, Netherlands, 3318AT
- Albert Schweitzer Ziekenhuis
-
Rotterdam, Zuid-Holland, Netherlands, 3079DZ
- Maasstad Ziekenhuis
-
Rotterdam, Zuid-Holland, Netherlands, 3045PM
- Sint Franciscus Vlietland Groep
-
The Hague, Zuid-Holland, Netherlands
- Haaglanden Medisch Centrum
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients over 18 years of age
- Receiving cardiopulmonary resuscitation, as defined by starting manual chest compressions, for a circulatory arrest occuring in-hospital.
- In hospital is defined as all hospital wards, departments, outpatient clinics, and hallways.
Exclusion Criteria:
- Children (<18 years of age)
- Purposely induced cardiac arrest (e.g. cardiac surgery)
- Purposely induced arrhythmias (e.g. electrophysiological treatment)
- Refusal to participate
- Primary out-of-hospital cardiac arrest with re-arrest <24h after hospital admission.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
one-year survival
Time Frame: one year
|
Survival one year after in-hospital cardiac arrest
|
one year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SF-12
Time Frame: 3 months and one year after in-hospital cardiac arrest
|
Quality of life measured by SF-12 questionnaire
|
3 months and one year after in-hospital cardiac arrest
|
EuroQoL
Time Frame: 3 months and one year after in-hospital cardiac arrest
|
Quality of life measured by EuroQoL questionnaire
|
3 months and one year after in-hospital cardiac arrest
|
HADS
Time Frame: 3 months and one year after in-hospital cardiac arrest
|
Quality of life measured by Hospital Anxiety and Depression Scale questionnaire
|
3 months and one year after in-hospital cardiac arrest
|
Charlson Comorbidity Index
Time Frame: 3 months and one year after in-hospital cardiac arrest
|
Development of new comorbidities as defined by the Charlson Comorbidity Index.
|
3 months and one year after in-hospital cardiac arrest
|
Cardiovascular events
Time Frame: 3 months and one year after in-hospital cardiac arrest
|
Development of new cardiovascular events (e.g.
myocardial infarction, stroke), by means of checkbox question.
|
3 months and one year after in-hospital cardiac arrest
|
Working life
Time Frame: Prior to in-hospital cardiac arrest and 3 months and one year after in-hospital cardiac arrest
|
Participation in working life; status before cardiac arrest and after by means of checkbox question.
|
Prior to in-hospital cardiac arrest and 3 months and one year after in-hospital cardiac arrest
|
TICS
Time Frame: 3 months after in-hospital cardiac arrest, if patients are not able to respond to regular questionnaires (paper)
|
Telephonic interview for Cognitive Status
|
3 months after in-hospital cardiac arrest, if patients are not able to respond to regular questionnaires (paper)
|
CSI
Time Frame: 3 months and one year after in-hospital cardiac arrest
|
Caregiver strain index for caregivers of In-Hospital Cardiac Arrest Survivors
|
3 months and one year after in-hospital cardiac arrest
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Robert Jan Stolker, MD PhD, Erasmus Medical Center
- Principal Investigator: Marc Schluep, MD, Erasmus Medical Center
- Study Chair: Sanne Hoeks, PhD, Erasmus Medical Center
- Study Chair: Henrik Endeman, MD PhD, OLVG
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ABR55661.078.16
- NTR6145 (Other Identifier: Dutch Trial Registry)
- MEC-2016-563 (Other Identifier: Erasmus MC METC)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Children's National Research InstituteRecruitingProfessional Quality of LifeUnited States
-
Istituto Ortopedico RizzoliUniversity of BolognaActive, not recruitingImprove Quality of LifeItaly
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHealth Related Quality of LifeUnited States
-
PharmanexSprim Advanced Life SciencesCompletedHealth-related Quality of LifeUnited States
-
Region VästmanlandUnknownHealth Related Quality of Life
-
Ain Shams UniversityCompletedHealth Related Quality of LifeEgypt
-
Institute of Oncology LjubljanaUnknownHealth-related Quality of LifeSlovenia